Neuroprotective effects of the SCR_1–3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats

References

• Komotar RJ, Kim GH, Often ML, Hassid B, Mocco J, Sughrue ME, et al.. The Role of complement in stroke therapy. Adv Exp Med Biol. 2008;632:23–33.
   PubMed Web of Science ®Google Scholar
• Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971;133:885–900.
   PubMed Web of Science ®Google Scholar
• Komotar RJ, Starke RM, Arias EJ, Garrett MC, Otten ML, Merkow MB, et al.. The complement cascade: new avenues in stroke therapy. Curr Vasc Pharmacol. 2009;7:287–92.
   PubMed Web of Science ®Google Scholar
• Ducruet AF, Zacharia BE, Hickman ZL, Grobelny BT, Yeh ML, Sosunov SA, et al.. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol. 2009;219:398–403.
   PubMed Web of Science ®Google Scholar
• De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am J Pathol. 2004;164:1857–63.
   PubMed Web of Science ®Google Scholar
• Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, et al.. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol. 2009;66:332–42.
   PubMed Web of Science ®Google Scholar
• Mocco J, Mack WJ, Ducruet AF, King RG, Sughrue ME, Coon AL, et al.. Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke. J Neurosurg. 2006;105:595–601.
   PubMed Web of Science ®Google Scholar
• Figueroa E, Gordon LE, Feldhoff PW, Lassiter HA. The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett. 2005;380:48–53.
   PubMed Web of Science ®Google Scholar
• Gorsuch WB, Guikema BJ, Fritzinger DC, Vogel CW, Stahl GL. Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury. Mol Immunol. 2009;47:506–10.
   PubMed Web of Science ®Google Scholar
• Banz Y, Rieben R. Role of complement and perspectives for intervention in ischemia-reperfusion damage. Ann Med. 2012;44:205–17.
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Takagawa H, Iwakaji H, Miyagawa S, Wang PC, Ishii N. Construction of the plasmid, expression by Chinese hamster ovary cell, purification and characterization of the first three short consensus repeat modules of human complement receptor type 1. J Biochem. 2009;145:533–42.
   PubMed Web of Science ®Google Scholar
• Krych-Goldberg M, Atkinson JP. Structure–function relationships of complement receptor type 1. Immunol Rev. 2001;180:112–22.
   PubMed Web of Science ®Google Scholar
• Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, Perkins SJ. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J Mol Biol. 2008;375:102–18.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang X, Wang Z. Cloning, expression of the SCR1–3 domains of human complement receptor type 1 and analysis of its activities. Immunol J. 2012;28:64–8.
   Google Scholar
• Li S, Xian J, He L, Luo X, Tan B, Yang Y, et al.. The protective effect of SCR(15–18) on cerebral ischemia-reperfusion injury. Neurol Res. 2011;33:866–74.
   PubMed Web of Science ®Google Scholar
• Molnar L, Hegedus K, Fekete I. Reversible experimental middle cerebral artery occlusion. Stroke. 1990;21:679–80.
   PubMed Web of Science ®Google Scholar
• Costa C, Zhao L, Shen Y, Su X, Hao L, Colgan SP, et al.. Role of complement component C5 in cerebral ischemia/reperfusion injury. Brain Res. 2006;1100:142–51.
   PubMed Web of Science ®Google Scholar
• Jia YJ, Min LQ, Ji ZS, Liu C. Influence of procyanidin on Bcl-2 and Bax after cerebral ischemia. Chin J Clin Rehabil. 2006;10:65–6+72.
   Google Scholar
• Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al.. Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem. 2008;105:1737–45.
   PubMed Web of Science ®Google Scholar
• Wagner E, Frank MM. Therapeutic potential of complement modulation. Nat Rev Drug Discov. 2010;9:43–56.
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Kirschfink M. Strategies of therapeutic complement inhibition. Mol Immunol. 2006;43:107–21.
   PubMed Web of Science ®Google Scholar
• Morrison H, Frye J, Davis-Gorman G, Funk J, McDonagh P, Stahl G, et al.. The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr Neurovasc Res. 2011;8:52–63.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res. 2010;209:119–22.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu J, Li L, Wang P, Ji X, Ai H, et al.. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull. 2010;83:196–201.
   PubMed Web of Science ®Google Scholar
• Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al.. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12:682–7.
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206–9.
   PubMed Web of Science ®Google Scholar
• Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, et al.. Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res. 2012;176:210–9.
   PubMed Web of Science ®Google Scholar
• Ansari MN, Bhandari U, Islam F, Tripathi CD. Evaluation of antioxidant and neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusion-induced oxidative stress in rats. Fundam Clin Pharmacol. 2008;22:305–14.
   PubMed Web of Science ®Google Scholar